Molecular cloning and characterisation of the rock bream, Oplegnathus fasciatus, Fas (CD95/APO-1), and its expression analysis in response to bacterial or viral infectionopen access
- Authors
- Jeong, J.-M.; Kim, J.-W.; Park, H.-J.; Song, J.-H.; Kim, D.-H.; Park, C.-I.
- Issue Date
- 2011
- Publisher
- Elsevier B.V.
- Keywords
- Death domain; Fas; Rock bream; RSIV; Streptococcus iniae
- Citation
- Results in Immunology, v.1, no.1, pp 11 - 17
- Pages
- 7
- Indexed
- SCOPUS
- Journal Title
- Results in Immunology
- Volume
- 1
- Number
- 1
- Start Page
- 11
- End Page
- 17
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/24691
- DOI
- 10.1016/j.rinim.2011.06.002
- ISSN
- 2211-2839
- Abstract
- Fas belongs to the tumour necrosis factor (TNF) receptor superfamily and can transmit a death signal leading to apoptosis. In the present study, we isolated the full-length cDNA for rock bream (Oplegnathus fasciatus) Fas (RbFas). The full-length RbFas cDNA was 1770 bp long and contained an open reading frame of 957 bp that encoded 319 amino acid residues with a predicted molecular mass of 35.1 kDa. The 319 amino-acid predicted RbFas sequence is homologous to other Fas sequences, contains three cysteine-rich domains and a death domain (DD) and two potential N-glycosylation sites. Expression of RbFas mRNA was detected in nine different tissues from healthy rock bream and was the highest in red blood cells. In analyses of mitogen-stimulated RbFas expression in peripheral blood leucocytes, expression of RbFas mRNA was observed between 1 and 36 h after stimulation with LPS, and 1 and 3 h stimulation with poly I:C. In the case of bacterial injection, the RbFas transcript peaked 6 h after injection in both the kidney and the spleen. Otherwise, the RbFas transcript peaked after 1 h in spleen and 6 h in kidney following injection with RSIV. ? 2011 Elsevier Ltd.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 해양과학대학 > ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.